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ABStrACt 
Introduction: Cryptococcus neoformans and Cryptococcus gattii are encapsulated basidiomycetous yeasts with worldwide distribution. 
They cause cryptococcosis with features of systemic infection, affecting the central nervous system, lungs and skin in humans and animals. 
These fungi present numerous virulence factors that allow them to invade the host and multiply, among which extracellular enzyme 
capacity and microbial adaptation to different temperatures are worth mentioning. Objective: To evaluate the production of protease and 
investigate possible differences in thermotolerance and urease activity in clinical and environmental yeast isolates. Material and methods: 
Culture methods and Pz analysis were applied to assess urease and protease, whereas the optical density method was used to analyze 
biological activity in thermotolerance. Results: There was no significant results as to microbial growth at the tested temperatures (25º, 37º 
and 42ºC). It was observed that clinical specimens grew better than environmental ones at elevated temperatures. As to C. neoformans, 
the moderate production of urease enzyme prevailed in both clinical and environmental isolates within 24h or 48h. Moreover, there was 
significant production on the seventh day of reading. The best reading time for viewing protease production in both isolates and species 
was the seventh day: 96% clinical samples and 94% environmental isolates. Conclusion: Further studies are required in order to investigate 
the virulence factors of C. neoformans and C. gattii cerebrospinal isolates from patients with meningoencephalitis and environmental 
samples from Sergipe. Furthermore, a higher technical accuracy and statistical precision are indispensable.
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introDuCtion
Cryptococcus neoformans and Cryptococcus gattii are 
encapsulated basidiomycetous yeasts with worldwide distribution. 
They cause cryptococcosis with features of systemic infection, 
affecting the central nervous system, lungs and skin in humans 
and animals(13, 18). For several years, C. neoformans was regarded 
as a single species with some varieties. Currently, there are two 
species: C. neoformans with two varieties (var. grubii – serotype 
A and var. neoformans – serotype D) and hybrid serotype AD; 
C. gattii (serotypes B and C)(14, 18). C. neoformans occurs mostly 
among immunocompromised individuals, mainly human 
immunodeficiency virus (HIV) patients. 
Cryptococcosis is among the top three opportunistic infections 
in patients with acquired immunodeficiency syndrome (AIDS), 
causing morbidity and mortality in this population(17-19, 25).
Meningoencephalitis caused by C. neoformans occurs 
in 6% to 8% of patients with AIDS(6). Cryptococcosis caused 
by C. gattii, unlike those caused by C. neoformans, occurs 
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mainly among healthy hosts and it is classically described 
as a tropical disease. Nevertheless, there was an outbreak of 
C. gattii on Vancouver Island, a temperate climate region, which 
suggests that C. gattii is not exclusively restricted to tropical and 
subtropical areas(13, 20). Cryptococcus gattii is endemic in the 
north and northeast regions of Brazil. It affects mostly children 
and young adults(25). Despite the fact that cryptococcosis is a 
systemic infection that affects mostly HIV patients, there are few 
studies on molecular epidemiology and clinical aspects, mainly 
in the northeast region of Brazil(8). Cryptococcal meningitis 
arises in 8% to 30% of AIDS patients and the mortality is high in 
6% to 29% of the cases(22).
C. neoformans has been isolated from bird excrements, 
plant debris and contaminated soil(5). It has also been found 
in plants such as Eucalyptus(9), Brazilian native plants(15) and 
armadillo burrows in the northeast of Brazil(10, 15, 16). C. gattii 
has been continuously isolated from Eucaliptus spp.(1, 9). 
It has also been isolated from Amazonian native plants(1, 10). 
Moreover, it has been found in animals from temperate regions 
such as dolphins (Tursiops truncatus) in the Atlantic ocean 
(Metropolitan region of Vancouver, Canada)(23). In this specific 
case, there was an epidemic affecting both immunocompetent 
and immunodeficient patients as well as animals (dogs and 
dolphins)(20, 23). Additionally, strains of this pathogenic yeast were 
found in plant species from Canada(23). This species was also 
found in wasps, bats, koalas, and camels(9, 15, 16). Both species are 
commonly isolated in hen excrements as well as deteriorating 
wood planks and trunks from living trees(15, 16).
Several factors are involved in the adherence process, 
destruction and invasion of host tissues. According to the 
literature, protease production, which ascertains a potential 
adaptability to adverse environments, is among them. In 
general, proteinases degrade several human proteins such as 
albumin, hemoglobin, keratin and immunoglobulin A (IgA), 
which are present in different sites. This proteolytic activity 
has been associated with tissue invasion and it is considered a 
virulence factor(14). 
These fungi have several virulence factors that allow 
invasion of the host and their multiplication(24). The present 
study evaluated protease production by Cryptococcus 
neoformans and Cryptococcus gattii and possible differences in 
enzymatic activity between clinical and environmental samples. 
Furthermore, it verified possible differences in thermotolerance 
and urease activity in clinical and environmental samples in 
order to confirm, albeit indirectly, these features as virulence 
factors. 
oBJECtivE
To observe the capacity of extracellular enzyme production 
(urease and proteinase) and biological activity in several 
temperatures (thermotolerance) in clinical and environmental 
isolates of Cryptococcus neoformans and Cryptococcus gattii 
from Sergipe, Brazil.
MAtEriAL AnD MEthoDS
Preparation of microbial strains 
70 strains were selected from the collection of the Applied 
Microbiology Laboratory - Universidade Federal de Sergipe (AML-
UFS), including 35 environmental isolates, 35 clinical isolates and 
two standard strains (ATCC 32608 and ATCC 56990). In the strain 
description, we analyzed 9 strains of Cryptococcus gattii and 26 
strains of Cryptococcus neoformans from cerebrospinal samples 
collected from patients with meningoencephalitis and assisted at 
Sergipe Emergency Hospital.
The surveyed pathogenic yeasts were isolated from several 
environmental samples from Sergipe, including 34 strains of 
Cryptococcus neoformans and 1 strain of Cryptococcus gattii. 
The environmental substrates were from bird and bat excrements 
as well as native and exotic tree trunks from Sergipe. The strains 
were inoculated in Sabouraud Dextrose and incubated at 25ºC for 
five days.
Ability to grow in thermotolerance
Five tubes/sample were employed for thermotolerance analysis. 
We inoculated 5 µl of suspension with 1.2 × 109 microorganisms/ml 
in each tube, which contained 3 ml of Sabouraud broth. Each 
tube was incubated at different temperatures (25ºC, 30ºC, 37ºC, 
40ºC and 42ºC). Turbidity readings were carried out through 
MacFarland standard and spectrophotometer within 24 hours, 
48 hours and seven-day incubation periods(4).
Enzymatic activity: urease 
For the assessment of urease activity, we employed Christensen 
agar (with Ph adjusted to 5.0) added to a 20% urea solution, 
distributed into slanted tubes (3 ml/tube). After inoculation, the 
samples were incubated at 25ºC and the readings were performed 
after 24 hours, 48 hours and seven days. The results were 
interpreted according to the following criteria: negative (medium 
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remained yellow), moderate activity (half of the medium became 
pink) and intense activity (the medium became entirely pink)(2).
Enzymatic activity: protease 
We applied plates with protease agar containing fraction V 
bovine albumin and Protovit, in which 5 µl of suspension with 
1.2 × 109 microorganisms/ml were inoculated in duplicate. 
The inoculated plates were incubated at 37ºC and the reading 
was conducted after seven days. Light areas around the colonies 
were interpreted as albumin degradation. The colonies (a) and 
the colonies plus light halo (b) were assessed. Protease activity 
was estimated through Pz calculation (a/b) so that the lower Pz, 
the higher the enzymatic activity. As positive controls, we used 
six endocervical samples of Candida spp. from AML-UFS strain 
database(3).
Statistical analysis of yielded data
All strains were statiscally analyzed through SPSS v. 11 and 
BioEstat v.5 software. They were also submitted to mean test and 
comparison between variables through student’s t – distribution 
(thermotolerance and protease) and ANOVA variance analysis 
(urease). Turkey test was performed after significant p < 0.01 for 
statistical data differentiation. 
rESuLtS
Table 1 shows the microbial concentration of Cryptococcus 
neoformans special complex in isolates from Sergipe, northeast 
of Brazil, when tested at different temperatures in order to assess 
thermotolerance.
Table 2 shows the optical density of clinical isolates of both 
surveyed yeasts (C. neoformans and C. gattii) for the analysis of 
growth under thermotolerance biological activity.
Table 3 demonstrates the mean concentrations of C. 
neoformans in environmental samples at the seventh day 
of incubation reading after carrying out thermotolerance 
experiments under the following temperatures: 25ºC, 30ºC, 37ºC, 
40ºC and 42ºC.
According to Table 4, when we analyze thermotolerance 
in environmental isolates, it is observable the diminishment in 
optical density in comparison with clinical isolates, though with 
no statistical difference when p < 0.01.
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tABLE 1 – Mean microorganism concentrations in the seventh day of thermotolerance  
reading and correlation of tested temperatures and strain origins
25ºC 30ºC 37ºC 40ºC 42ºC
Clinical (35) 9.5 × 108 15.5 × 108 7.4 × 108 3.7 × 108 7.6 × 108
environmental (35) 9 × 108 11.5 × 108 9.7 × 108 4.6 × 108 3.1 × 108
p value (t-test) 0.574 0.012* 0.368 0.698 0.040*
* There was statistical difference when t Test was conducted (p < 0.01).
tABLE 2 – Mean microorganism concentrations in the seventh day of thermotolerance reading with only clinical samples
25ºC 30ºC 37ºC 40ºC 42ºC
Clinical/C. neoformans (26) 8.5 × 108 12.5 × 108 9.7 × 108 2.9 × 108 6.3 × 108
Clinical/C.gattii (9) 7 × 108 8.5 × 108 8.8 × 108 2.6 × 108 3.4 × 108
p value (t-test) 0.574 0.012* 0.368 0.698 0.040*
* There was statistical difference when t Test was conducted (p < 0.01).
tABLE 3 – Mean microorganism concentrations in the seventh day of thermotolerance reading with only environmental samples
25ºC 30ºC 37ºC 40ºC 42ºC
Environmental/ 
C. neoformans (34)
7.5 × 108 9.5 × 108 7.9 × 108 2.7 × 108 7.9 × 108
Environmental/ 
C.gattii (1)
7 × 108 6.7 × 108 6.7 × 108 1.6 × 108 3.4 × 108
p value (t-test) 0.574 0.012* 0.368 0.698 0.040*
* There was statistical difference when t Test was conducted (p < 0.01).
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Table 5 shows statistical studies on optical density and 
comparison of surveyed temperatures in C. neoformans isolates 
from both clinical and environmental sites. 
Table 5 corroborates data shown in Table 4.
Table 6 presents the profile of urease production in 70 
surveyed pathogenic yeasts by comparing both environmental and 
clinical isolated sites.
Table 7 indicates C. neoformans urease production in both 
environmental and clinical isolates after 24 hours, 48 hours and 
seven days.
tABLE 4 – Statistical correlation between mean concentration  
of Cryptococcus neoformans isolates under thermotolerance  
and differences in test temperatures
25ºC × 37ºC 25ºC × 42ºC 37ºC × 42ºC
Clinical/ 
C. neoformans (26)
0.069 0.152 0.882
Environmental/ 
C. neoformans (34)
0.717 0.0* 0.005*
p value (t-test) 0.744 0.012* 0.040*
* There was statistical difference when t Test was conducted (p < 0.01).
tABLE 5 – Statistical correlation between mean concentration  
of Cryptococcus gattii isolates under thermotolerance  
and the differences in test temperatures
25ºC × 37ºC 25ºC × 42ºC 37ºC × 42ºC
Clinical/C. gattii (9) 0.032 0.121 0.701
Environmental/C. 
gattii (34)
0.68 0.015* 0.015*
p value (t-test) 0.689 0.018* 0.020*
* There was statistical difference when t Test was conducted (p < 0.01).
tABLE 6 – Urease production activity in clinical and environmental Cryptococcus neoformans  
and Cryptococcus gattii samples isolated in Sergipe, Brazil
24 hours 48 hours 7th day
Negative Moderate Intense Negative Moderate Intense Negative Moderate Intense
Clinical (35) 0a 35b 0 0 a 35a 0 0 1a 34b
Environmental (35) 1a 32b 2c 1a 32b 2c 1a 2b 1a
ATCC 32608 0 1 0 0 1 0 0 0 1
ATCC 569900 0 1 0 0 1 0 0 0 1
Total 1 69 2 1 69 2 1 3 68
a, b, c: ANOVA test (p < 0.01) followed by Turkey test for statistical data differentiation in all surveyed sites.
ANOVA: variance analysis.
tABLE 7 – Urease production activity in clinical and environmental Cryptococcus neoformans samples isolated in Sergipe, Brazil
24 hours 48 hours 7th day
Negative Moderate Intense Negative Moderate Intense Negative Moderate Intense
Clinical (26) 0 26a 0 0 26ª 0 0 0 26a
Environmental (34) 1a 31b 2c 1a 31b 2c 1a 2b 31c
Total 1 57 2 1 57 2 1 28 65
a, b, c: ANOVA test (p < 0.01) followed by Turkey test for statistical data differentiation in all surveyed sites.
ANOVA: variance analysis.
Table 8 shows urease enzymatic production in C. gattii 
strains in both environmental and clinical isolates. 
Table 9 demonstrates protease production in Cryptococcus 
neoformans and Cryptococcus gattii in both environmental and 
clinical isolates from the collection of UFS/AML.
Table 10 shows protease enzymatic activity of C. neoformans 
from both clinical and environmental sites after 24 hours, 
48 hours and seven days. 
Table 11 shows data on protease production in C. gattii 
strains from both environmental and clinical isolates after 
24 hours, 48 hours and seven days. 
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DiSCuSSion
There was statistical difference between environmental and 
clinical isolates when p < 0.01, regardless of the yeast species 
tested at 30ºC and 42ºC. There was statistical uniformity in optical 
density for other temperatures. It is particularly worth mentioning 
tABLE 8 – Urease production activity in clinical and environmental Cryptococcus gattii samples isolated in Sergipe, Brazil
24 hours 48 hours 7th day
Negative Moderate Intense Negative Moderate Intense Negative Moderate Intense
Clinical (9) 0 9ª 0 0 9a 0 0 1a 8b
Environmental (1) 0 1 0 0 1 0 0 0 1
Total 1 57 2 1 57 2 1 28 65
a, b: ANOVA test (p < 0.01) followed by Turkey test for statistical data differentiation in all surveyed sites.
ANOVA: variance analysis.
tABLE 9 – Protease production activity in clinical and environmental Cryptococcus neoformans  
and Cryptococcus gattii samples isolated in Sergipe, Brazil
24 hours 48 hours 7th day
Negative Intense Negative Intense Negative Intense
Clinical (35) 34a 1b 12a 23b 1a 34b
Environmental (35) 35a 0 4a 31b 2a 33b
ATCC 32608 0 1 0 1 0 1
ATCC 56990 1 0 1 0 1 0
Total 70 2 17 55 4 68
a, b: ANOVA test (p < 0.01) followed by Turkey test for statistical data differentiation in all surveyed sites.
ANOVA: variance analysis.
tABLE 10 – Protease production activity in clinical and environmental Cryptococcus neoformans samples isolated in Sergipe, Brazil
24 hours 48 hours 7th day
Negative Intense Negative Intense Negative Intense
Clinical (26) 26a 0 8a 18b 1a 25b
Environmental (34) 34a 0 4a 30b 2a 32b
Total 60 0 12 48 3 57
a, b:  ANOVA test (p < 0.01) followed by Turkey test for statistical data differentiation in all surveyed sites.
ANOVA: variance analysis.
tABLE 11 – Protease production activity in clinical and environmental Cryptococcus gattii samples isolated in Sergipe, Brazil
24 hours 48 hours 7th day
Negative Intense Negative Intense Negative Intense
Clinical (9) 8a 1b 4a 5a 0 9
Environmental (1) 1 0 0 1 0 1
Total 9 1 4 6 0 10
a, b: ANOVA test (p < 0.01) followed by Turkey test for statistical data differentiation in all surveyed sites.
ANOVA: variance analysis.
that in terms of fungal growth there was no statistical difference 
between environmental and clinical isolates and the strains (70) 
when surveyed at body temperature(37ºC).
The most significant increase in the descriptive data on both 
clinical and environmental isolates occurred at the following 
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temperatures: 42ºC, 40ºC, 37ºC, 30ºC and 25ºC. It is important 
to highlight that the typical average temperature of the studied 
region is 30ºC.
It was observed that there was statistical difference in both species 
at 30ºC and 42ºC. There was no statistical difference in the other 
temperatures. There was growth in C. neoformans and C. gattii 
clinical isolates at 30ºC and 37ºC, as shown in Table 1. The worst 
thermotolerance and optical density relation was 40ºC temperature.
As it was mentioned in the previous tables, there was statistical 
difference at 30ºC and 42ºC in comparison with other temperatures. 
In these pathogenic yeasts isolated from environmental sites in the 
state of Sergipe, the highest optical density for C. neoformans was 
at the following temperatures: 37ºC and 30ºC. On the other hand, 
C. gattii showed higher optical density for clinical isolates at 30ºC 
and 37ºC and for environmental isolates at 25ºC, 30ºC and 37ºC.
There was statistical difference in the optical density of this 
yeast when we compared the following temperatures: 25ºC and 
37ºC with 42ºC. There was no statistical difference for the other 
temperatures. It may be inferred that it is difficult to obtain 
reference optical density for thermotolerance test at 42ºC, that is 
to say that there is fungal growth inhibition, mainly when this 
temperature is required in order to obtain bioproducts and/or 
bioprocesses relevant to the health area. 
By confronting data on C. gattii, though p values were more 
significant, there was no homogeneity in the statistical analysis of 
optical density and thermotolerance.
As to thermotolerance, when mean microorganism 
concentrations from clinical and environmental samples were 
compared at different temperatures and after seven days, there 
was significant statistical difference at 30ºC (p < 0.05) and 42ºC 
(p < 0.05). There was no difference at other temperatures (Tables 2 
and 3). By using t test, it was observed that there was no significant 
statistical difference in the comparison of mean microorganism 
concentrations from clinical samples at different temperatures, 
contrasting with environmental samples, in which there was 
significant statistical difference in the following comparisons: 
25ºC vs. 42ºC (p < 0.001) and 37ºC vs. 42ºC (p < 0.001). 
The use of microbial growth in several temperatures, mainly in 
the occurrence of circulating strains, specially in the northeast of 
Brazil and in plant and animal samples, provides information on the 
epidemiological aspects of these yeasts (virulence factors) as well as 
their ecology (biological activity). However, there was no significant 
result as to microbial growth neither at the tested temperatures (25ºC, 
37ºC and 42ºC) nor at the contrasted ones. In high temperatures 
(30ºC and 42ºC), the clinical samples presented a higher growth 
with statistical significance in comparison with environmental ones. 
Moreover, the clinical samples grew regardless of the incubation 
temperature, which did not occur with environmental ones.
Casadevall et al. claim that thermotolerance (at 37ºC) is a 
singular phenomenon in the triggering of systemic mycoses. 
Therefore, the yeast with this featured virulence factor maximizes 
the triggering of this disease in humans. Zuyderduyn et al. state 
that, as far as thermotolerance is concerned, there are several genes 
involved in the pathogenesis of these fungi. By use of serial analysis 
of gene expression, the following genes were present: translation 
elongation factor 1, cyclophilin A, thioredoxin peroxidase, histone 
H4, ribosomal proteins 40S RPS12 60S RPL21A. The studied strain 
was C. neoformans H99(26).
In the analysis of urease production, there was statistical 
difference in the adopted temperatures for the analysis of 
enzymatic production (24 hours, 48 hours and seven days) in 
both clinical and environmental isolates. In the clinical isolates, 
there was statistical prevalence of moderate production within 24 
and 48 hours. All isolates produced it (100%). After the seventh 
day of enzymatic analysis, only the clinical strain remained with 
moderate production whereas the other 34 strains produced urease 
intensely. There were statistical differences among these data.
As to environmental samples, there was prevalence of moderate 
urease production in the following readings: 24 and 48 hours. 32 
from the total of 35 surveyed strains produced it moderately, one did 
not produce it and two produced it intensely. There were statistical 
differences in all cases. In the seventh day of reading, 32 from the 
total 35 strains showed intense production, two revealed moderate 
production and one did not produce urease. It is worth highlighting 
that there were statistical differences within yielded data.
As to clinical samples, it was possible to notice that both 24 
and 48- hours periods yielded a moderate production of urease 
(100% of strains). In the seventh day of reading, eight from nine 
strains produced the enzyme intensely whereas one isolate revealed 
moderate production. In these cases, there were statistical differences 
when ANOVA test was adopted (p < 0.01) followed by Turkey test. 
The only strain of C. gattii isolated from environmental substrate 
in the state of Sergipe produced the enzyme moderately within both 
periods (24 and 48 hours). In the seventh day, there was an intense 
production of this enzyme, corroborating other yielded data.
Ato urease production, there were statistical differences 
when we compared data from 24 and 48- hours reading periods 
with the seventh day of data analysis. The moderate enzymatic 
production prevailed in C. neoformans environmental isolates 
within both 24 and 48- hours periods. In the seventh day, these 
strains progressed to intense production of urease. Analyzing the 
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data from environmental isolates, there was also uniformity in the 
enzymatic production within 24 and 48- hours periods. 31 from 34 
surveyed strains produced the enzyme moderately, one strain did 
not produce it and two produced it intensely. In the seventh day of 
reading, there was intense enzymatic production in 31 from the 
total of 34 surveyed strains and one of them did not produce any 
enzyme. There were statistical differences in these data. Therefore, 
it may be inferred that C. neoformans yields better results for 
urease in the seventh day of stimulus for enzymatic production. 
Urease is an enzyme from the microbial metabolism that 
plays a major role as a virulence factor of several pathogenic 
agents such as 
Cryptococcus neoformans and Cryptococcus gattii(3, 4, 24). 
Urease hydrolyses urea in ammonia and carbamate, resulting 
in local pH increase, which may be applied in microbial 
identification as a result from colorimetric changes. Most 
C. neoformans clinical isolates are positive for urease(2). Perfect 
et al.(21) verified that C. neoformans strains that were negative 
for urease through the inactivation of the gene responsible for 
the enzymatic production had lower pathogenicity in comparison 
with the wild mutant reconstituted type, which was demonstrated 
by the survival of the sample after inoculation. 
By use of ANOVA test, it was possible to notice that there was a 
significant statistical difference between clinical and environmental 
samples. As to urease activity, all types of samples hydrolyzed urea 
fast, regardless of its type (clinical or environmental).
Torres-Rodríguez et al.(12) report that there are several variables 
influencing this virulence factor, namely microbial biomass used 
in the experiment and test accuracy. In the same investigation, 
they demonstrated that Cryptococcus neoformans had a higher 
enzymatic activity or urease production in comparison with 
Cryptococcus gattii, which was not corroborated in the present 
study. Hsueh et al.(11) reported the occurrence of moderate urease 
activity (37.5%) in C. neoformans special complex isolates from 
Taiwan after 48 hours and low activity in urease production 
(62.5%). These data differ from our present findings. Thus, 
the strains from this investigation presented potential urease 
production, which causes higher pathogenicity. 
Other virulence factors involved in Cryptococcus neoformans 
and Cryptococcus gattii pathogenicity are the following enzymes: 
lipases, proteinases and proteases. They are involved in the 
destruction of cellular structures in order to offer nutrients to the 
pathogenic fungi and facilitate their systemic propagation(7).
Casadevall et al.(3) showed that proteinase is able to degrade 
proteins from the host, namely collagen, elastin, fibrinogen, 
immunoglobulins and proteins from the complement system. 
Furthermore, the authors highlighted that this host protein 
degradation may protect C. neoformans from the immune system 
by blocking phagocytosis. 
In the data analysis based on proteinase production by 
encapsulated pathogenic yeasts, the reading time for the visualization 
of this enzyme in both sites (clinical and environmental) was 48 
hours. For the clinical strains, 34 strains did not produce proteinase 
and one did within 24 hours whereas 12 strains did not produce 
proteinase and 23 did within 48 hours. In the seventh day of 
enzymatic reading, only one strain remained without producing the 
enzyme, whereas 34 strains did. It is particularly worth mentioning 
that there were statistical differences with result selection (p < 0.01) 
in all data and studied periods.
As to environmental samples, 100% of them showed no 
enzymatic production within 24 hours. 31 from 35 strains showed 
enzymatic production and only four strains showed none within 
48 hours. In the seventh day of analysis, two from the total of 
four isolates that did not produce any reading within 48 hours 
remained without synthesizing the enzyme. In the last period, 33 
strains produced proteinase. Standard Cryptococcus neoformans 
(ATCC 32608) and Cryptococcus gattii (ATCC56990) strains were 
used for test standardization. Standard ATCC32608 showed enzyme 
production in all surveyed periods whereas ATCC 56990 strains did 
not synthesize the enzyme during the experiment. 
100% of the strains did not produce the enzyme in neither of 
the sites within 24 hours. 18 clinical samples produced proteinase 
and eight did not synthesize it within 48 hours. As to environmental 
samples, 30 from 34 surveyed samples produced the enzyme. In 
the seventh day of biological reading, only one clinical sample and 
two environmental samples did not produce it. During this period, 
there was enzyme production in 25 clinical and 32 environmental 
samples. In the analyzed periods, there was statistical difference 
with data selection at p < 0.01.
In the clinical C. gattii samples, eight from nine strains did 
not produce proteinase and one did within 24 hours. There was 
no statistical difference when we analyzed the production or 
absence of proteinase within 48 hours. Four from nine strains 
remained without producing whereas five did. In the studies on 
C. gattii virulence factors, the number of isolates was lower, which 
also influenced statistical analysis of experimental data. In the 
seventh day, 100% of clinical C. gattii synthesized proteinase. The 
only environmental C. gatti sample that produced proteinase was 
within 48 hours.
As to proteinase production, when Pz values from clinical and 
environmental samples were compared through ANOVA test, there was 
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significant statistical difference (p = 0.66). Souza et al.(24) report that 
isolates from Amazonas showed a high protease production (Pz < 
0.64) with mean Pz = 0.3 for both Cryptococcus species, supporting 
the information found herein and implying the great potential in the 
production of this virulence factor in the studied pathogenic yeasts.
New studies with higher technical accuracy and precise 
data analysis are required to assess the virulence factors and 
biological activity of these encapsulated pathogenic yeasts 
from cerebrospinal samples collected from patients with 
meningoencephalitis attended at Sergipe Emergency Hospital as 
well as strains from several environmental sites (bird and pigeon 
excrements, guano, hen coops and native exotic tree hollows) 
from different areas in Sergipe. The collection of microorganism 
cultures, implementation of new technologies, establishment 
of partnerships and studies on microbial biodiversity point 
towards new directions and objectives in the epidemiological 
and ecological analysis of these yeasts as well as their endemic 
behavior in the northeast of Brazil. 
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rESuMo 
Introdução: Cryptococcus neoformans e Cryptococcus gattii são leveduras encapsuladas basidiomicéticas com distribuição mundial. 
Causam criptococose com características de infecção sistêmica, afetando o sistema nervoso central, pulmão e pele em humanos 
e animais. Esses fungos possuem inúmeros fatores de virulência que permitem invadir o hospedeiro e se multiplicar, entre eles 
destacam-se a capacidade enzimática extracelular e a adaptação microbiana a diversas temperaturas. Objetivo: Avaliar a produção 
de proteinase por essas leveduras, de isolados clínicos e ambientais, além de verificar possíveis diferenças na termotolerância e 
na atividade da urease. Material e métodos: Para urease e proteinase, foi utilizado o sistema de cultivo e análise Pz. Já para 
atividade biológica em termotolerância, foi analisado o método de densidade óptica. Resultados: Não há resultado significativo 
no crescimento, mesmo nas temperaturas testadas (25º, 37º e 42ºC). Foi verificado que, em temperaturas elevadas, as amostras 
clínicas cresceram melhor que as ambientais. Para C. neoformans, tanto nos isolados ambientais como nos clínicos, em 24h ou 
48h, prevaleceu a produção moderada da enzima urease. Já no sétimo dia de leitura, houve produção significativa. O melhor 
tempo de leitura para visualização da produção de proteinase em ambos isolados e espécies foi no sétimo dia, sendo: 96% amostras 
clínicas e 94% ambientais. Conclusão: São necessários novos estudos acerca da determinação dos fatores de virulência de C. 
neoformans e C. gattii isolados de liquor oriundos de pacientes com meningoencefalite e amostras ambientais em Sergipe, além 
de maior acuidade técnica e precisão estatística dos resultados.   
Unitermos: Cryptococcus neoformans; proteínas fúngicas; micologia; leveduras; Cryptococcus gattii.
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